Ascentage Starts China Trial of Apoptosis Cancer Drug

Life Science

HitGen Approved for $97 Million IPO on Shanghai’s STAR Board

Life Science

Miaoshou Doctor Completes $73 Million C+ Round at $1 Billion Valuation

Life Science

Novartis Plans to File 50 NDAs in China over the Next Five Years

Life Science

Johnson & Johnson to test HIV vaccine in US and Europe

Life Science

Collaboration with US med schools helps Rwanda improve women’s health care

Life Science

Gilead Sciences Plans Western China Ops Center in Chengdu

Life Science

Scripps Research Snags $129 Million for HIV Vaccine Investigation

Life Science

Invitae to Acquire Jungla to Advance Genetic Variant Interpretation, Adds Supplemental RNA Analysis to Deliver Deeper, More Informative Results to Patients

Life Science

SinoMab Bioscience, a Hong Kong Biotech, to IPO on Hong Kong Exchange

Life Science

CStone Starts China Bridging Trial of GIST Candidate

Life Science

MacroGenics and I-Mab Announce Exclusive Collaboration and License Agreement to Develop and Commercialize Enoblituzumab in Greater China

Life Science

SI Group Announces Focused Sale Of Industrial Resin Business to ASK Chemicals

Life Science

China News Weekly 118 – Huawei Led China Mainland Innovation in First Half, Registering 2,314 Patents

Financial Service, Life Science, Mining, Technology

ADC Therapeutics Rakes in $303 Million with Addition to its Series E

Life Science